XML 15 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock Shares
Additional Paid-in Capital
Retained Earnings
AOCL
Total Equity - Greenbrier
Noncontrolling Interest
Equity Excluding Contingently Redeemable Noncontrolling Interest
Contingently Redeemable Noncontrolling Interest
Beginning balance at Aug. 31, 2023     $ 364.4 $ 897.5 $ (7.3) $ 1,254.6 $ 155.6 $ 1,410.2  
Beginning balance (in shares) at Aug. 31, 2023   30,900              
Beginning balance at Aug. 31, 2023                 $ 55.6
Net earnings $ 66.8     64.6   64.6 1.8 66.4 0.4
Other comprehensive income (loss), net (1.6)       (1.6) (1.6)   (1.6)  
Noncontrolling interest adjustments             1.6 1.6  
Joint venture partner distribution declared             (4.4) (4.4)  
Restricted stock awards (net of cancellations)     14.1     14.1   14.1  
Restricted stock awards (net of cancellations) (in shares)   200              
Unamortized restricted stock     (19.2)     (19.2)   (19.2)  
Stock based compensation expense     8.1     8.1   8.1  
Repurchase of stock (1.3)   (1.3)     (1.3)   (1.3)  
Cash dividends       (19.4)   (19.4)   (19.4)  
Ending balance at Feb. 29, 2024     366.1 942.7 (8.9) 1,299.9 154.6 1,454.5  
Ending Balance (in shares) at Feb. 29, 2024   31,100              
Ending Balance at Feb. 29, 2024                 56.0
Beginning balance at Nov. 30, 2023     361.3 919.1 (6.4) 1,274.0 157.1 1,431.1  
Beginning balance (in shares) at Nov. 30, 2023   31,100              
Beginning balance at Nov. 30, 2023                 56.5
Net earnings 33.6     33.4   33.4 0.7 34.1 (0.5)
Other comprehensive income (loss), net (2.5)       (2.5) (2.5)   (2.5)  
Noncontrolling interest adjustments             1.2 1.2  
Joint venture partner distribution declared             (4.4) (4.4)  
Restricted stock awards (net of cancellations)     3.7     3.7   3.7  
Unamortized restricted stock     (3.6)     (3.6)   (3.6)  
Stock based compensation expense     4.7     4.7   4.7  
Cash dividends       (9.8)   (9.8)   (9.8)  
Ending balance at Feb. 29, 2024     366.1 942.7 (8.9) 1,299.9 154.6 1,454.5  
Ending Balance (in shares) at Feb. 29, 2024   31,100              
Ending Balance at Feb. 29, 2024                 56.0
Beginning balance at Aug. 31, 2024 $ 1,536.6   375.1 1,035.0 (34.0) 1,376.1 160.5 1,536.6  
Beginning balance (in shares) at Aug. 31, 2024 31,135 31,100              
Beginning balance at Aug. 31, 2024                 41.7
Net earnings $ 105.3     107.2   107.2 (1.4) 105.8 (0.5)
Other comprehensive income (loss), net (6.8)       (6.8) (6.8)   (6.8)  
Noncontrolling interest adjustments             7.9 7.9  
Joint venture partner distribution declared             (6.7) (6.7)  
Restricted stock awards (net of cancellations)     12.6     12.6   12.6  
Restricted stock awards (net of cancellations) (in shares)   300              
Unamortized restricted stock     (18.1)     (18.1)   (18.1)  
Stock based compensation expense     8.7     8.7   8.7  
Cash dividends       (19.5)   (19.5)   (19.5)  
Ending balance at Feb. 28, 2025 $ 1,620.5   378.3 1,122.7 (40.8) 1,460.2 160.3 1,620.5  
Ending Balance (in shares) at Feb. 28, 2025 31,387 31,400              
Ending Balance at Feb. 28, 2025                 41.2
Beginning balance at Nov. 30, 2024     373.8 1,080.5 (41.6) 1,412.7 162.3 1,575.0  
Beginning balance (in shares) at Nov. 30, 2024   31,400              
Beginning balance at Nov. 30, 2024                 43.1
Net earnings $ 46.2     51.9   51.9 (3.8) 48.1 (1.9)
Other comprehensive income (loss), net 0.8       0.8 0.8   0.8  
Noncontrolling interest adjustments             3.5 3.5  
Joint venture partner distribution declared             (1.7) (1.7)  
Restricted stock awards (net of cancellations)     1.3     1.3   1.3  
Unamortized restricted stock     (1.3)     (1.3)   (1.3)  
Stock based compensation expense     4.5     4.5   4.5  
Cash dividends       (9.7)   (9.7)   (9.7)  
Ending balance at Feb. 28, 2025 $ 1,620.5   $ 378.3 $ 1,122.7 $ (40.8) $ 1,460.2 $ 160.3 $ 1,620.5  
Ending Balance (in shares) at Feb. 28, 2025 31,387 31,400              
Ending Balance at Feb. 28, 2025                 $ 41.2